濮阳东方评价很高濮阳东方医院妇科治病专业,濮阳东方医院男科治疗早泄好不,濮阳东方妇科治病便宜,濮阳东方医院做人流手术很好,濮阳东方医院妇科做人流口碑很好价格低,濮阳东方医院看阳痿值得选择,濮阳东方医院收费咨询

The Supreme Court decided on Monday that they will not reexamine a doctrine that protects law enforcement and government officials from being sued over their actions while on the job.The doctrine, which the justices created nearly 50 years ago, gives "qualified immunity" for law enforcement officers, which protects them from frivolous lawsuits CNN reported.The decision comes amid protests over the death of George Floyd, who died while in police custody in Minneapolis.According to CBS News, the courts were to hear one case about a man in Tennessee that was bitten by a police dog, although he was sitting on the ground with his hands raised.NPR reports that two justices, Sonia Sotomayor and Clarence Thomas, have both been skeptical of the doctrine. 763

The Trump Administration pushed through a million contract to study whether the active ingredient in Pepcid is an effective treatment for Covid-19. That contract is now under scrutiny after a government whistleblower accused a senior administration official of rushing the deal through without the scientific oversight necessary for such a large federal award. The Food and Drug Administration gave the clinical trial speedy approval even as a top agency official worried that daily injections of high doses of famotidine for already sick patients pushed the levels of what was considered safe “to the limits,” internal government emails show. And the doctors who initially pushed the Pepcid idea are locked in a battle for credit and sniping over allegations of scientific misconduct.The origins of the interest in famotidine are under dispute, but there were reports out of China that patients who took the drug survived the virus, while patients who took other heartburn medications were not surviving. Initial observational studies in the U.S. were promising, however scientists urged more research was needed. Meantime, the trial itself that was part of the million contract is on pause due to a shortage of hospitalized COVID-19 patients in New York, delaying it indefinitely. A vaccine or effective treatment could be available before the study is complete. 1380

The two children who were rescued from an RV after an hours-long chase ended in Kern County, California have been reunited with their mother. The Los Angeles County Sheriff's Office posted pictures on Twitter at about 2 a.m. Wednesday, showing the children with their mom at an office. LACSO says both children were unharmed following Tuesday's pursuit.  377

The strain of E. coli causing the current outbreak in romaine lettuce has been found in a reservoir on a farm in Santa Barbara County, California, the US Food and Drug Administration and Centers for Disease Control and Prevention announced Thursday.The agencies are continuing to investigate other possible sources, and the CDC still advises consumers not to eat romaine lettuce grown in California's Monterey, San Benito and Santa Barbara counties until investigations are complete."We cannot say how many cases are linked to this specific farm at this time," Ian Williams, chief of the CDC's outbreak response and prevention branch, said at a press briefing. "We have to do additional work at this farm and other farms that are being identified from our investigation."Properly labeled romaine grown outside those three counties and harvested after November 23, as well as romaine grown in greenhouses or hydroponically, should all be safe from contamination, the CDC said. The earlier warning against eating romaine from California's San Luis Obispo, Santa Cruz and Ventura counties has been lifted.The agency stressed that consumers should continue to avoid any romaine lettuce not labeled with the harvest date and location.The CDC has identified another seven illnesses since its update December 6, bringing the total people infected with E. coli to 59 across 15 states and Washington, D.C. The last reported illness was November 16. There have been 23 hospitalizations and two cases of hemolytic uremic syndrome, a type of kidney failure. No deaths have been reported.While calling it "premature" to call the outbreak over, Williams said it was a good sign that the most recently identified cases were in the same time period as the main outbreak."We're hopeful that it's moving in the right direction," Williams said. "It's still too early to tell."The first cases in this outbreak were identified in October. States with cases include California, Connecticut, Florida, Illinois, Louisiana, Massachusetts, Maryland, Michigan, New Hampshire, New Jersey, New York, Ohio, Pennsylvania, Rhode Island and Wisconsin. 2141

The US Food and Drug Administration expanded?the list of drugs being recalled that contain valsartan. The drug is used as a component in a set of drugs used to treat heart failure and blood pressure.New to the list are some valsartan products manufactured by Hetero Labs Ltd. in India, which are labeled as Camber Pharmaceuticals Inc. Test results show that some of the products may be tainted.The FDA announced a valsartan recall in July after lab tests revealed that some drugs could have been tainted with a substance linked to higher risk of cancer. The drug had been recalled in 22 other countries. The expanded recall includes some drugs that contain valsartan and hydrochlorothisazide. Not all of the drugs containing valsartan were affected.N-nitrosodimethylamine or NDMA, the impurity the lab tests found, is considered a?possible carcinogen by the US Environmental Protection Agency. It is an organic chemical that has been used to make liquid rocket fuel, and it can be unintentionally introduced through certain chemical reactions. It's a byproduct of the manufacturing of some pesticides and fish processing.The medicines that are now a part of this expanded list?in the recall are tablets sold by AvKare, A-S Medication Solutions LLC, Bryant Ranch Prepack Inc, Camber Pharmaceuticals, Inc. H J Harkins Company, Northwind Pharmaceuticals, NuCare Pharmaceuticals Inc., Prinston Pharmaceutical Inc. (labeled as Solco Healthcare LLC), Proficient Rx LP, Remedy Repack, Teva Pharmaceuticals (labeled as Major Pharmaceuticals), Teva Pharmaceuticals USA (labeled as Actavis).The FDA also published a list of valsartan products that are not currently recalled. Only the drugs suspected of being tainted with NDMA are on the recall list. If you are taking a valsartan drug, look for the company name on your prescription bottle. If the information isn't on the label, you can call your pharmacy for those details.The recalled medicine is linked to a manufacturer in China. The substances were supplied by Zhejiang Huahai Pharmaceuticals, based in Linhai, in eastern China, which said it notified authorities as soon as it identified the impurity."We published our recall notice at midday on July 13 in China and overseas, and published the US market recall notice on July 14 Beijing time ... all the drug materials for the Chinese market were recalled by July 23," the company said in a statement to the Shanghai stock exchange last month.The FDA said on its website that it's working with drug manufacturers "to ensure future valsartan active pharmaceutical ingredients are not at risk."If you are worried that your drug could be on the recall list, talk with your doctor or pharmacist before changing any routine with your medicine. Because not all valsartan drugs are involved in the recall, they might be able to switch you to a version of the drug made by another company.If you know your drug is on the recall list, the FDA suggests you continue taking it until your doctor or pharmacist provides a replacement.To get a sense of what taking a tainted drug could mean, FDA scientists estimated that if 8,000 people took the highest dose of valsartan (320 milligrams) from the recalled batches every day for four years, there may be one additional case of cancer."The key with this is, patients should not stop taking their medication abruptly, that definitely can be harmful," Dr. Mary Ann Bauman, a representative for the American Heart Association, said in July. "You don't want to jump to any conclusions on your own about this medication, or any medication for that matter. Definitely talk with your doctor first." 3690